RE: Tick tock7 Jun 2022 13:52
Oh, how I know that feeling!
My concern is less so the share price right now, nor even our lack of any giagantic discoveries (although assuming we appraise Egyptian Vulture that may open the door for a "massive discovery" in my book), but the seeming lack of any haste from the BOD to do anything about cash flows.
This exploration route has always felt like a cop out to me, because they wouldn't pay enough for buying cash flows and weren't fast enough when it mattered. Even then, now we have tradable assets, they don't exactly seem to be in any rush to swap them for cash flows.
The problem, is that while they may be shareholders, a shareholder who is also taking a salary doesn't have the same pressures as one who isn't, or is taking a small salary.
I probably wouldn't be complaining if Cambozola came in, but TBF, it only had a 15% COS, so it wasn't likely and we all knew that.
The thing is, even firms that aren't doing mega boepd figures, but are in sensible jurisdictions like KIST (pre recent deal it was on ~5k boepd) have had massive rises, because it is very easy to value cash flows.
Exploration is a gamble at the end of the day and in light of the ESG moves being made by major fund managers, the BOD really need cash flows so that the question marks over future funding can be quashed.
Right now they have:
- 15% of 19-63mmboe at Egyptian Vulture.
- 20% of 9-12mmboe at Rodhette and there seemms to be a question over the commercialisation of this.
- Mugnetind doesn't count as its not commercial in isolation.
-10% of 28-48mmboe at Kveikje
So at the low end LBE have net 7.45mmboe, which at $5/boe is worth $37.25m, or £30m, which is pretty much our market cap.
Frustrating, but down here the valuation seems about right with what we currently know, unless they buy production or find some more oil and gas.